Effect of standardized extract of Marsilea minuta on learning and memory performance in rat amnesic models

References

• Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH. (1999). Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol, 56, 1121–1123.
   PubMedGoogle Scholar
• Bhattamisra SK, Khanna VK, Agrawal AK, Singh PN, Singh SK. (2008). Antidepressant activity of standardised extract of Marsilea minuta Linn. J Ethnopharmacol, 117, 51–57.
   PubMed Web of Science ®Google Scholar
• Bhattamisra SK, Singh PN, Singh SK, Kumar V. (2007). Anxiolytic activity of Marsilea minuta Linn. J Herb Med Toxicol, 1, 15–20.
   Google Scholar
• Blockland A. (1996). Acetylcholine: A neurotransmitter for learning and memory? Brain Res Rev, 21, 285–300.
   Google Scholar
• Chatterjee A, Dutta CP, Choudhury B, Dey PK, Dey CD, Chaterjee C, Mukherjee SR. (1963). The chemistry and pharmacology of marsiline: a sedative and anticonvulsant principle isolated from Marsilea minuta Linn and Marsilea rajasthanensis Gupta. J Exp Med Sci, 7, 53–67.
   PubMedGoogle Scholar
• Das A, Dikshit M, Singh HK, Nath C. (2003). Evaluation of effect of scopolamine on stages of active avoidance learning in rats. Indian J Pharmacol, 35, 47–50.
   Google Scholar
• de Angelis L, Furlan C. (1995). The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol Learn Mem, 64, 119–124.
   PubMedGoogle Scholar
• Dilts SL, Berry CA. (1967). Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exp Ther, 158, 279–285.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, 88–95.
   PubMed Web of Science ®Google Scholar
• Enz A, Amstutz R, Boddeke H, Gmelin G, Malanowski J. (1993). Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer’s disease. Prog Brain Res, 98, 431–438.
   PubMed Web of Science ®Google Scholar
• Giacobini E. (2003). Cholinergic function and Alzheimer’s disease. Int J Geriatr Psychiatry, 18, S1–S5.
   Web of Science ®Google Scholar
• Giurgea C. (1973). The “nootropic” approach to the pharmacology of the integrative activity of the brain. Cond Reflex, 8, 108–115.
   PubMedGoogle Scholar
• Glowinski J, Iversen LL. (1966). Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]DOPA in various regions of the brain. J Neurochem, 13, 655–669.
   PubMed Web of Science ®Google Scholar
• Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. (1999). Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem, 264, 672–686.
   PubMedGoogle Scholar
• Gupta M, Mazumder UK, Datta I, Battacharya S, Mukherjee S, Manikandan L. (2002). Studies of antifertility activity of Marsilea minuta Linn. Indian J Pharm Sci, 64, 176–178.
   Google Scholar
• Itoh J, Nabeshima T, Kameyama T. (1990). Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berl), 101, 27–33.
   PubMed Web of Science ®Google Scholar
• King RA, Glasser RL. (1970). Duration of electroconvulsive shock-induced retrograde amnesia in rats. Physiol Behav, 5, 335–339.
   PubMedGoogle Scholar
• Le Merrer J, Noguès X. (2000). Cognitive neuropharmacology: New perspectives for the pharmacology of cognition. Pharmacol Res, 41, 503–514.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Mesulam M. (2004). The cholinergic lesion of Alzheimer’s disease: pivotal factor or side show? Learn Mem, 11, 43–49.
   PubMed Web of Science ®Google Scholar
• Nadkarni AK. (1976). Indian Materia. Vol-I. Bombay, India: Popular Prakashan, 662–663.
   Google Scholar
• Norman KA, O’Reilly RC. (2003). Modeling hippocampal and neocortical contributions to recognition memory: A complementary-learning-systems approach. Psychol Rev, 110, 611–646.
   PubMed Web of Science ®Google Scholar
• Ogren SO. (1982). Central serotonin neurons and learning in rats. In: Osborne NN, ed. Biology of Serotonergic Transmission. Chichester: Wiley, 317.
   Google Scholar
• Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A. (1981). Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging, 2, 251–256.
   PubMedGoogle Scholar
• Pilch H, Müller WE. (1988). Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice. Psychopharmacology (Berl), 94, 74–78.
   PubMedGoogle Scholar
• Rubaj A, Zgodzinski W, Sieklucka-Dziuba M. (2003). The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment. Behav Brain Res, 141, 11–17.
   PubMedGoogle Scholar
• Rupniak NM, Tye SJ, Field MJ. (1997). Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys. Psychopharmacology (Berl), 131, 406–410.
   PubMed Web of Science ®Google Scholar
• Russell RW. (1996). Continuing the search for cholinergic factors in cognitive dysfunction. Life Sci, 58, 1965–1970.
   PubMedGoogle Scholar
• Scheuer K, Rostock A, Bartsch R, Müller WE. (1999). Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain. Pharmacopsychiatry, 32 Suppl 1, 10–16.
   PubMedGoogle Scholar
• Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. (1997). Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int, 30, 181–190.
   PubMed Web of Science ®Google Scholar
• Seth PK, Agrawal AK, Bondy SC. (1981). Biochemical changes in the brain consequent to dietary exposure of developing and mature rats to chlordecone (kepone). Toxicol Appl Pharmacol, 59, 262–267.
   PubMed Web of Science ®Google Scholar
• Seth PK, Alleva FR, Balazs T. (1982). Alteration of high-affinity binding sites of neurotransmitter receptors in rats after neonatal exposure to streptomycin. Neurotoxicology, 3, 13–19.
   PubMedGoogle Scholar
• Siddiqui MF, Levey AI. (1999). Cholinergic therapies in Alzheimer’s disease. Drugs Future, 24, 417–444.
   Google Scholar
• Sivarajan VV, Balachandran I. (1994). Ayurvedic Drugs and Their Plant Sources. New Delhi, India: Oxford & IBH Publishing Co.Pvt.Ltd., 455.
   Google Scholar
• Smith RD, Kistler MK, Cohen-Williams M, Coffin VL. (1996). Cholinergic improvement of a naturally-occurring memory deficit in the young rat. Brain Res, 707, 13–21.
   PubMed Web of Science ®Google Scholar
• Tiwari OP, Bhattamisra SK, Tripathi PK, Singh PN. (2010). Anti-aggressive activity of a standardized extract of Marsilea minuta Linn. in rodent models of aggression. Biosci Trends, 4, 190–194.
   PubMed Web of Science ®Google Scholar
• Vogel GH, Vogel WH. (2002). Drug Discovery and Evaluation: Pharmacological Assays. Berlin: Springer Verlag.
   Google Scholar
• Wagner H, Bladt S, Zgainski EM. (1984). Plant Drug Analysis: A Thin Layer Chromatography Atlas. Berlin, Heidelberg: Springer Verlag.
   Google Scholar